Latest AB Science News & Updates

See the latest news and media coverage for AB Science. We track all announcements, press releases, and industry mentions in real time, all in one place.

AB Science

Biopharmaceutical company developing small molecule drugs

ab-science.com

Last updated October 9

Latest news about AB Science

In short: AB Science reported 2026 results, clinical advances, capital raises, patents, and governance changes.

Company announcements

October 9 AB Science

AB Science reports first half 2026 revenues and activity updates

The company provided its financial results for the first six months of 2026. It also shared an operational update regarding recent activities.

September 29 AB Science

AB Science revises its development plan and financial calendar

The revision follows a for cause sponsor Good Clinical Practice inspection conducted during September 2026.

August 10 AB Science

AB Science completes capital increases totaling EUR 14.2 million

The capital increases were subscribed by a limited number of investors, raising additional funds for the company.

July 10 AB Science

AB Science narrows clinical focus to two programs

It discontinues non-priority studies to concentrate on AB8939 for AML and masitinib for ALS.

Media coverage

September 28 Le Devoir

AB Science provides an update on its development plan and financial calendar following a sponsor inspection...

Confirmation of the relevance of having, among the first managerial decisions, given priority to the development of a new quality assurance system Preliminary resumption of the phase...

May 13 Salisbury Post

AB Science reports its revenues for the year 2025 and provides an update on its...

FR0010557264 - AB) today announces its annual financial results as of 31 December 2025 and provides an update on its activities. AB Science announced in...

April 27 Yahoo Finance

AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors

a 24-month capital grace period from the opening date of the first conciliation procedure in favour of AB Science, i.e. January 17, 2025, with resumption...

August 24, 2022 Seeking Alpha

AB Science announces that it has filed an application for conditional Marketing Authorization to EMA for masitinib in the treatment of ALS

AB Science SA (Euronext - FR0010557264 - AB) today announced that it has filed an application for conditional Marketing Authorization to the European Medicines Agency...

Never miss news about AB Science

Track AB Science and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.